Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    Kuru
Show Display Options
RSS Create an RSS feed from your search for:
Kuru
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Probiotic Yoghurt Effect on Experimental Gingivitis
Condition: Gingivitis
Interventions: Dietary Supplement: Probiotic Yoghurt;   Dietary Supplement: Natural Yoghurt
2 Completed Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft
Conditions: Periodontal Bone Loss;   Chronic Periodontitis
Interventions: Procedure: Open Flap Debridement;   Biological: EmdogainⓇ(Enamel Matrix Derivative);   Biological: EmdogainⓇEnamel Matrix Derivative+Autogenous Bone
3 Completed Effect of Topically-Applied Hyaluronic-Acid on Palatal Epithelial Wound Closure
Condition: Wound Healing Complication
Interventions: Drug: Periodontal dressing material;   Drug: 0.2% Hyaluronic acid gel;   Drug: 0.8% Hyaluronic acid gel
4 Completed Is There a Relationship Between Hyperlipidemia and Periodontitis?
Condition: Hyperlipidemia, Periodontal Disease
Intervention: Other: No intervention was applied
5 Recruiting Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Condition: Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Interventions: Drug: Placebo capsules;   Drug: Bardoxolone methyl capsules
6 Recruiting Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Combined Pulmonary Fibrosis and Emphysema
Interventions: Drug: Inhaled Treprostinil;   Drug: Placebo
7 Recruiting Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Interventions: Drug: Bardoxolone methyl;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.